John Cox, CEO & President at Dyne Therapeutics, Inc. (DYN), bought 15,200 shares at $33.09 ($503K) on 2024-09-04, disclosed to the SEC on 2024-09-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.57 | 800 | $26K | 5.2% |
| 2 | $33.09 | 7,200 | $238K | 47.4% |
| 3 | $33.09 | 7,200 | $238K | 47.4% |
| Total | $33.06 avg | 15,200 | $503K | 100% |
| Filing → |
| DYN | SELL | 2026-06-17 | $49K | — | Filing → |
| DYN | SELL | 2026-05-14 | $61K | — | Filing → |
| DYN | SELL | 2026-03-06 | $41K | — | Filing → |